Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
biotech ipos
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
2
×
bristol-myers squibb
cancer
clinical trials
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
life sciences
merck
2
×
national
national blog main
national top stories
new york blog main
new york top stories
nkarta
pfizer
raleigh-durham blog main
2
×
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
vir biotechnology
wisconsin blog main
wisconsin top stories
What
bio
roundup
advantages
alliance
bar
brings
bristol
buy
calls
changing
color
crispr
days
drug
expect
gamble
growing
hours
kudos
leaves
market
medco’s
mover
myers’s
new
notifying
october
patients
payers
phone
physicians
plan
pricing
rnai
rouse
scientists
sets
shorter
slumber
time
Language
unset
Current search:
bridgebio
×
" clinical trials "
×
" raleigh-durham blog main "
×
merck
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone